| scholarly article | Q13442814 |
| P356 | DOI | 10.1007/S10549-008-0261-5 |
| P8608 | Fatcat ID | release_fp24udxsg5dwrnvqxt5bteamza |
| P698 | PubMed publication ID | 19115106 |
| P2093 | author name string | D B Evans | |
| M Evans | |||
| M Wilson | |||
| S M Ali | |||
| A Lipton | |||
| K Leitzel | |||
| L Demers | |||
| M N Vo | |||
| P2860 | cites work | Endoglin expression in metastatic breast cancer cells enhances their invasive phenotype | Q24307831 |
| P433 | issue | 3 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | metastatic breast cancer | Q12859063 |
| P304 | page(s) | 767-771 | |
| P577 | publication date | 2008-12-30 | |
| P1433 | published in | Breast Cancer Research and Treatment | Q326085 |
| P1476 | title | Elevated plasma endoglin (CD105) predicts decreased response and survival in a metastatic breast cancer trial of hormone therapy | |
| P478 | volume | 119 |
| Q52714924 | Antagonizing CD105 enhances radiation sensitivity in prostate cancer. |
| Q35878752 | Antibody colocalization microarray: a scalable technology for multiplex protein analysis in complex samples |
| Q45396887 | CD105 (Endoglin) expression in breast carcinoma effusions is a marker of poor survival |
| Q47198219 | Durable remission for a woman with refractory choriocarcinoma treated with anti-endoglin monoclonal antibody and bevacizumab: A case from the New England Trophoblastic Disease Center, Brigham and Women's Hospital and Dana-Farber Cancer Institute |
| Q38180309 | Endoglin for targeted cancer treatment |
| Q34614196 | Endoglin suppresses human prostate cancer metastasis |
| Q93015590 | Preclinical Efficacy of Endoglin-Targeting Antibody-Drug Conjugates for the Treatment of Ewing Sarcoma |
| Q42483948 | Tumor angiogenesis as prognostic and predictive marker for chemotherapy dose-intensification efficacy in high-risk breast cancer patients within the WSG AM-01 trial |
Search more.